Ipamorelin 10mg Peptides
Precision begins at the molecular level—this is Ipamorelin prepared for controlled, repeatable research.
The Primavora Ipamorelin 10mg lyophilized peptide vial is a research-use-only formulation in our GH peptide category. Presented as a freeze-dried powder in a sealed vial, this single-ingredient preparation provides a total content of 10mg, offering a clean, consistent starting point for protocols that prioritize accuracy and reproducibility.
- Each vial contains 10mg of Ipamorelin, a selective growth hormone secretagogue investigated for its receptor-driven, pulsatile growth hormone release profile with minimal impact on cortisol and prolactin in research settings.
Developed for laboratory workflows, the lyophilized format supports stability during storage and transport, and is suited for qualified handling and reconstitution in controlled environments. Researchers utilize Ipamorelin to explore ghrelin receptor (GHSR-1a) activity, growth hormone axis dynamics, and time-dependent secretion patterns in experimental systems. Its selectivity profile enables focused study designs where targeted signal evaluation and minimized off-target endocrine interference are priorities.
Primavora emphasizes material integrity at every stage—from sourcing to final fill. Each lot is produced under controlled conditions, lot-tracked for traceability, and verified by independent laboratories for identity and purity to support consistent performance across studies. Certificates of Analysis are available by lot to provide full transparency on analytical verification. This Ipamorelin vial contains no blended additives, allowing researchers to design protocols around a defined, single active component.
As a USA-based research brand, Primavora is built on rigorous standards, careful handling, and documentation that supports confident, methodical work. Our approach centers on purity, consistency, and reliability so that investigators can focus on data quality rather than material variability.
For laboratory research only. Not for human consumption, medical, or veterinary use. Handle with appropriate laboratory safety practices and in accordance with institutional guidelines. Store and manage according to your lab’s validated procedures to maintain the integrity of the peptide and the reproducibility of results.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a growth-hormone secretagogue that acts primarily through the ghrelin receptor pathway. It is often described as more selective than older secretagogues because it is studied for GH release with less interest in off-target hormone stimulation. For product copy, it should be described as a research peptide for endocrine signaling studies.
What is Ipamorelin typically studied for?
Ipamorelin is typically studied for endogenous growth-hormone release, GH/IGF-1-axis signaling, recovery-related models, and pulse-based endocrine research. It is commonly paired with GHRH analogs in blend products because those two signaling routes are often examined together.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
